| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2002 | Stack EC, Balakrishnan R, Numan MJ, Numan M. A functional neuroanatomical investigation of the role of the medial preoptic area in neural circuits regulating maternal behavior. Behavioural Brain Research. 131: 17-36. PMID 11844569 DOI: 10.1016/S0166-4328(01)00370-9 | 0.447 | |||
| 2000 | Stack EC, Numan M. The temporal course of expression of c-Fos and Fos B within the medial preoptic area and other brain regions of postpartum female rats during prolonged mother--young interactions. Behavioral Neuroscience. 114: 609-22. PMID 10883811 DOI: 10.1037//0735-7044.114.3.609 | 0.447 | |||
| Low-probability matches (unlikely to be authored by this person) | |||||
| 1999 | Rapp PR, Stack EC, Gallagher M. Morphometric studies of the aged hippocampus: I. Volumetric analysis in behaviorally characterized rats. The Journal of Comparative Neurology. 403: 459-70. PMID 9888312 DOI: 10.1002/(Sici)1096-9861(19990125)403:4<459::Aid-Cne3>3.0.Co;2-9 | 0.277 | |||
| 2009 | Datta S, Siwek DF, Stack EC. Identification of cholinergic and non-cholinergic neurons in the pons expressing phosphorylated cyclic adenosine monophosphate response element-binding protein as a function of rapid eye movement sleep. Neuroscience. 163: 397-414. PMID 19540313 DOI: 10.1016/J.Neuroscience.2009.06.035 | 0.231 | |||
| 2005 | Stack EC, Kubilus JK, Smith K, Cormier K, Del Signore SJ, Guelin E, Ryu H, Hersch SM, Ferrante RJ. Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice. The Journal of Comparative Neurology. 490: 354-70. PMID 16127709 DOI: 10.1002/Cne.20680 | 0.21 | |||
| 2013 | Werner L, Bellmunt J, Nikitas N, Stack EC, Lis R, Signoretti S, Loda M, Regan MM, Park RS, O'Brien R, Berman DM, Bamias A, Rosenberg JE. Relationship of ERCC1 genotype variant with mRNA expression and ERCC1 protein levels in advanced urothelial carcinoma (UC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 260. PMID 28136860 DOI: 10.1200/jco.2013.31.6_suppl.260 | 0.169 | |||
| 2007 | Stack EC, Dedeoglu A, Smith KM, Cormier K, Kubilus JK, Bogdanov M, Matson WR, Yang L, Jenkins BG, Luthi-Carter R, Kowall NW, Hersch SM, Beal MF, Ferrante RJ. Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 12908-15. PMID 18032664 DOI: 10.1523/Jneurosci.4318-07.2007 | 0.168 | |||
| 2010 | Stack EC, Desarnaud F, Siwek DF, Datta S. A novel role for calcium/calmodulin kinase II within the brainstem pedunculopontine tegmentum for the regulation of wakefulness and rapid eye movement sleep. Journal of Neurochemistry. 112: 271-81. PMID 19860859 DOI: 10.1111/J.1471-4159.2009.06452.X | 0.15 | |||
| 2015 | Mullane SA, Werner L, Guancial EA, Lis RT, Stack EC, Loda M, Kantoff PW, Choueiri TK, Rosenberg J, Bellmunt J. Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma. Clinical Genitourinary Cancer. PMID 26778300 DOI: 10.1016/J.Clgc.2015.12.029 | 0.145 | |||
| 2015 | Martin NE, Gerke T, Sinnott JA, Stack EC, Andren O, Andersson SO, Johansson JE, Fiorentino M, Finn S, Fedele G, Stampfer M, Kantoff PW, Mucci LA, Loda M. Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer. Molecular Cancer Research : McR. PMID 26124442 DOI: 10.1158/1541-7786.Mcr-14-0569 | 0.139 | |||
| 2015 | Tyekucheva S, Martin NE, Stack EC, Wei W, Vathipadiekal V, Waldron L, Fiorentino M, Lis RT, Stampfer MJ, Loda M, Parmigiani G, Mucci LA, Birrer M. Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues. The Journal of Molecular Diagnostics : Jmd. 17: 374-81. PMID 25937617 DOI: 10.1016/J.Jmoldx.2015.02.002 | 0.137 | |||
| 2013 | Xu K, Wu ZJ, Groner AC, He HH, Cai C, Stack EC, Loda M, Liu T, Morrissey C, Vessella RL, Kantoff PW, Balk SP, Liu XS, Brown M. Polycomb-independent activity of EZH2 in castration resistant prostate cancer Epigenetics & Chromatin. 6. DOI: 10.1186/1756-8935-6-S1-O14 | 0.136 | |||
| 2017 | Pettersson A, Gerke T, Penney KL, Lis RT, Stack EC, Pértega-Gomes N, Zadra G, Tyekucheva S, Giovannucci EL, Mucci LA, Loda M. MYC overexpression at the protein and mRNA level and cancer outcomes among men treated with radical prostatectomy for prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29141848 DOI: 10.1158/1055-9965.Epi-17-0637 | 0.131 | |||
| 2009 | Del Signore SJ, Amante DJ, Kim J, Stack EC, Goodrich S, Cormier K, Smith K, Cudkowicz ME, Ferrante RJ. Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 10: 85-94. PMID 18618304 DOI: 10.1080/17482960802226148 | 0.122 | |||
| 2014 | Guancial EA, Werner L, Bellmunt J, Bamias A, Choueiri TK, Ross R, Schutz FA, Park RS, O'Brien RJ, Hirsch MS, Barletta JA, Berman DM, Lis R, Loda M, Stack EC, et al. FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder. Cancer Medicine. 3: 835-44. PMID 24846059 DOI: 10.1002/Cam4.262 | 0.121 | |||
| 2012 | Xu K, Wu ZJ, Groner AC, He HH, Cai C, Lis RT, Wu X, Stack EC, Loda M, Liu T, Xu H, Cato L, Thornton JE, Gregory RI, Morrissey C, et al. EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science (New York, N.Y.). 338: 1465-9. PMID 23239736 DOI: 10.1126/Science.1227604 | 0.118 | |||
| 2012 | Riester M, Werner L, Molins JB, Selvarajah S, Weir B, Stack EC, Park RS, O'Brien R, Schutz FAB, Choueiri TK, Signoretti S, Gallardo E, Rojo F, Lloreta Trull J, Marchionni L, et al. External validation of somatic copy number alteration (SCNA) at chromosome 1q23.3 in advanced urothelial carcinoma (UC). Journal of Clinical Oncology. 30: 4585-4585. DOI: 10.1200/Jco.2012.30.15_Suppl.4585 | 0.114 | |||
| 2011 | Sullivan CP, Jay AG, Stack EC, Pakaluk M, Wadlinger E, Fine RE, Wells JM, Morin PJ. Retromer disruption promotes amyloidogenic APP processing. Neurobiology of Disease. 43: 338-45. PMID 21515373 DOI: 10.1016/J.Nbd.2011.04.002 | 0.113 | |||
| 2015 | Bellmunt J, Werner L, Bamias A, Fay AP, Park RS, Riester M, Selvarajah S, Barletta JA, Berman DM, de Muga S, Salido M, Gallardo E, Rojo F, Guancial EA, Bambury R, ... ... Stack E, et al. HER2 as a target in invasive urothelial carcinoma. Cancer Medicine. 4: 844-852. PMID 25720673 DOI: 10.1002/Cam4.432 | 0.111 | |||
| 2013 | Qu AQ, Jacobus SJ, Signoretti S, Stack EC, Krajewski KM, Rosenberg JE, Choueiri TK. Phase II study of neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) chemotherapy in patients with muscle-invasive urothelial cancer (MI-UC): Pathologic and radiologic response, serum tumor markers, and DNA excision repair pathway biomarkers in relation to disease-free survival (DFS). Journal of Clinical Oncology. 31: 4530-4530. DOI: 10.1200/jco.2013.31.15_suppl.4530 | 0.107 | |||
| 2012 | Grisanzio C, Werner L, Takeda D, Awoyemi BC, Pomerantz MM, Yamada H, Sooriakumaran P, Robinson BD, Leung R, Schinzel AC, Mills I, Ross-Adams H, Neal DE, Kido M, Yamamoto T, ... ... Stack EC, et al. Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. 109: 11252-7. PMID 22730461 DOI: 10.1073/Pnas.1200853109 | 0.102 | |||
| 2007 | Stack EC, Del Signore SJ, Luthi-Carter R, Soh BY, Goldstein DR, Matson S, Goodrich S, Markey AL, Cormier K, Hagerty SW, Smith K, Ryu H, Ferrante RJ. Modulation of nucleosome dynamics in Huntington's disease. Human Molecular Genetics. 16: 1164-75. PMID 17403718 DOI: 10.1093/Hmg/Ddm064 | 0.099 | |||
| 2006 | Stack EC, Smith KM, Ryu H, Cormier K, Chen M, Hagerty SW, Del Signore SJ, Cudkowicz ME, Friedlander RM, Ferrante RJ. Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice. Biochimica Et Biophysica Acta. 1762: 373-80. PMID 16364609 DOI: 10.1016/J.Bbadis.2005.11.002 | 0.097 | |||
| 2008 | Stack EC, Ferro JL, Kim J, Del Signore SJ, Goodrich S, Matson S, Hunt BB, Cormier K, Smith K, Matson WR, Ryu H, Ferrante RJ. Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease. Biochimica Et Biophysica Acta. 1782: 151-62. PMID 18206128 DOI: 10.1016/J.Bbadis.2007.12.006 | 0.096 | |||
| 2004 | Fink JS, Kalda A, Ryu H, Stack EC, Schwarzschild MA, Chen JF, Ferrante RJ. Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage. Journal of Neurochemistry. 88: 538-44. PMID 14720203 DOI: 10.1046/J.1471-4159.2003.02145.X | 0.095 | |||
| 2014 | Flavin R, Pettersson A, Hendrickson WK, Fiorentino M, Finn S, Kunz L, Judson GL, Lis R, Bailey D, Fiore C, Nuttall E, Martin NE, Stack E, Penney KL, Rider JR, et al. SPINK1 protein expression and prostate cancer progression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4904-11. PMID 24687926 DOI: 10.1158/1078-0432.Ccr-13-1341 | 0.095 | |||
| 2017 | Saab J, Santos-Zabala ML, Loda M, Stack EC, Hollmann TJ. Fatty Acid Synthase and Acetyl-CoA Carboxylase Are Expressed in Nodal Metastatic Melanoma But Not in Benign Intracapsular Nodal Nevi. The American Journal of Dermatopathology. PMID 28654463 DOI: 10.1097/DAD.0000000000000939 | 0.094 | |||
| 2013 | Pettersson A, Lis RT, Meisner A, Flavin R, Stack EC, Fiorentino M, Finn S, Graff RE, Penney KL, Rider JR, Nuttall EJ, Martin NE, Sesso HD, Pollak M, Stampfer MJ, et al. Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG. Journal of the National Cancer Institute. 105: 1881-90. PMID 24292212 DOI: 10.1093/Jnci/Djt332 | 0.093 | |||
| 2012 | Rosenberg JE, Werner L, Bamias A, Choueiri TK, Schutz FAB, Park RS, O'Brien R, Guancial EA, Ross RW, Berman DM, Riester M, Lis R, Loda MF, Stack EC, Michor F, et al. FGFR3 protein expression and gene mutation in primary and metastatic urothelial carcinoma (UC) tumors. Journal of Clinical Oncology. 30: 4577-4577. DOI: 10.1200/Jco.2012.30.15_Suppl.4577 | 0.093 | |||
| 2014 | Yoo S, Pettersson A, Jordahl KM, Lis RT, Lindstrom S, Meisner A, Nuttall EJ, Stack EC, Stampfer MJ, Kraft P, Brown M, Loda M, Giovannucci EL, Kantoff PW, Mucci LA. Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2027-31. PMID 24925673 DOI: 10.1158/1055-9965.Epi-14-0020 | 0.09 | |||
| 2012 | Pettersson A, Graff RE, Bauer SR, Pitt MJ, Lis RT, Stack EC, Martin NE, Kunz L, Penney KL, Ligon AH, Suppan C, Flavin R, Sesso HD, Rider JR, Sweeney C, et al. The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1497-509. PMID 22736790 DOI: 10.1158/1055-9965.EPI-12-0042 | 0.09 | |||
| 2007 | Stack EC, Ferrante RJ. Huntington's disease: progress and potential in the field. Expert Opinion On Investigational Drugs. 16: 1933-53. PMID 18042002 DOI: 10.1517/13543784.16.12.1933 | 0.09 | |||
| 2013 | Lunardi A, Ala U, Epping MT, Salmena L, Clohessy JG, Webster KA, Wang G, Mazzucchelli R, Bianconi M, Stack EC, Lis R, Patnaik A, Cantley LC, Bubley G, Cordon-Cardo C, et al. A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nature Genetics. 45: 747-55. PMID 23727860 DOI: 10.1038/Ng.2650 | 0.089 | |||
| 2020 | Taube JM, Akturk G, Angelo M, Engle EL, Gnjatic S, Greenbaum S, Greenwald NF, Hedvat CV, Hollmann TJ, Juco J, Parra ER, Rebelatto MC, Rimm DL, Rodriguez-Canales J, Schalper KA, ... Stack EC, et al. The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation. Journal For Immunotherapy of Cancer. 8. PMID 32414858 DOI: 10.1136/jitc-2019-000155 | 0.086 | |||
| 2015 | Gerke TA, Martin NE, Ding Z, Nuttall EJ, Stack EC, Giovannucci E, Lis RT, Stampfer MJ, Kantoff PW, Parmigiani G, Loda M, Mucci LA. Evaluating a 4-marker signature of aggressive prostate cancer using time-dependent AUC. The Prostate. 75: 1926-33. PMID 26469352 DOI: 10.1002/Pros.23090 | 0.085 | |||
| 2014 | Selvarajah S, Pyne S, Chen E, Sompallae R, Ligon AH, Nielsen GP, Dranoff G, Stack E, Loda M, Flavin R. High-resolution array CGH and gene expression profiling of alveolar soft part sarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 1521-30. PMID 24493828 DOI: 10.1158/1078-0432.CCR-13-2090 | 0.085 | |||
| 2015 | Gerke TA, Martin NE, Ding Z, Nuttall EJ, Stack EC, Giovannucci E, Lis RT, Stampfer MJ, Kantoff PW, Parmigiani G, Loda M, Mucci LA. Evaluating a 4-marker signature of aggressive prostate cancer using time-dependent AUC Prostate. DOI: 10.1002/pros.23090 | 0.081 | |||
| 2012 | Park RS, Werner L, Greulich H, de Muga S, Salido M, Stack EC, Lis R, Schutz FAB, Lloreta Trull J, Gallardo E, Rojo F, Berman DM, Molins JB, Rosenberg JE. Multidimensional investigation of HER2 in advanced urothelial carcinoma (UC). Journal of Clinical Oncology. 30: 4580-4580. DOI: 10.1200/jco.2012.30.15_suppl.4580 | 0.081 | |||
| 2013 | Jia S, Gao X, Lee SH, Maira SM, Wu X, Stack EC, Signoretti S, Loda M, Zhao JJ, Roberts TM. Opposing effects of androgen deprivation and targeted therapy on prostate cancer prevention. Cancer Discovery. 3: 44-51. PMID 23258246 DOI: 10.1158/2159-8290.Cd-12-0262 | 0.08 | |||
| 2013 | Jacobus SJ, Qu AQ, Sweeney C, Appleman LJ, Tretter CP, Bubley GJ, Elfiky A, Park R, Stack EC, Signoretti S, Walsh MK, Steele G, Hirsch MS, Krajewski KM, Taplin ME, et al. A phase II multicenter study of neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) chemotherapy with pegfilgrastim support in patients (pts) muscle-invasive urothelial cancer (MIUC): Safety, pathologic, radiologic, and molecular correlates. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 278. PMID 28136747 DOI: 10.1200/jco.2013.31.6_suppl.278 | 0.076 | |||
| 2013 | Iyer G, Riester M, Werner L, Schultz N, Stack EC, Park R, Loda M, Ostrovnaya I, Kantoff PW, Bajorin DF, Solit DB, Michor F, Bellmunt J, Rosenberg JE. Peroxisome proliferator-activated receptor gamma (PPARG) gene amplifications in urothelial carcinoma (UC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 279. PMID 28136741 DOI: 10.1200/Jco.2013.31.6_Suppl.279 | 0.074 | |||
| 2018 | Gartrell RD, Marks DK, Hart TD, Li G, Davari DR, Wu A, Blake Z, Lu Y, Askin KN, Monod A, Esancy CL, Stack EC, Jia DT, Armenta PM, Fu Y, et al. Quantitative Analysis of Immune Infiltrates in Primary Melanoma. Cancer Immunology Research. PMID 29467127 DOI: 10.1158/2326-6066.Cir-17-0360 | 0.074 | |||
| 2022 | Weaver JD, Stack EC, Buggé JA, Hu C, McGrath L, Mueller A, Wong M, Klebanov B, Rahman T, Kaufman R, Fregeau C, Spaulding V, Priess M, Legendre K, Jaffe S, et al. Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody. Oncoimmunology. 11: 2141007. PMID 36352891 DOI: 10.1080/2162402X.2022.2141007 | 0.074 | |||
| 2012 | Guancial EA, Werner L, Stack E, Lis R, Signoretti S, Loda M, Gallardo E, Rojo F, Lloreta J, Regan MM, Park R, O'Brien R, Berman DM, Bellmunt J, Rosenberg JE. Association of DNA repair factors with overall survival in advanced urothelial carcinoma treated with platinum-based chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 291. PMID 27968111 DOI: 10.1200/jco.2012.30.5_suppl.291 | 0.073 | |||
| 2016 | Yuan J, Hegde PS, Clynes R, Foukas PG, Harari A, Kleen TO, Kvistborg P, Maccalli C, Maecker HT, Page DB, Robins H, Song W, Stack EC, Wang E, Whiteside TL, et al. Novel technologies and emerging biomarkers for personalized cancer immunotherapy. Journal For Immunotherapy of Cancer. 4: 3. PMID 26788324 DOI: 10.1186/S40425-016-0107-3 | 0.071 | |||
| 2006 | Smith KM, Matson S, Matson WR, Cormier K, Del Signore SJ, Hagerty SW, Stack EC, Ryu H, Ferrante RJ. Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice. Biochimica Et Biophysica Acta. 1762: 616-26. PMID 16647250 DOI: 10.1016/J.Bbadis.2006.03.004 | 0.069 | |||
| 2014 | Stack EC, Wang C, Roman KA, Hoyt CC. Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. Methods (San Diego, Calif.). 70: 46-58. PMID 25242720 DOI: 10.1016/j.ymeth.2014.08.016 | 0.063 | |||
| 2020 | Lunardi A, Ala U, Epping MT, Salmena L, Clohessy JG, Webster KA, Wang G, Mazzucchelli R, Bianconi M, Stack EC, Lis R, Patnaik A, Cantley LC, Bubley G, Cordon-Cardo C, et al. Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nature Genetics. PMID 32884149 DOI: 10.1038/S41588-020-0701-7 | 0.062 | |||
| 2014 | Rodig SJ, Stack EC. Untangling the tumor microenvironment: Illuminating the complex interactions and functions of immune cells Science. 346: 1247.3-1247. DOI: 10.1126/science.346.6214.1247-c | 0.061 | |||
| 1913 | Stack EC. A NEW AXIS TRACTION FORCEPS. The Lancet. 181: 180. | 0.06 | |||
| 2014 | Wagle N, Grabiner BC, Van Allen EM, Hodis E, Jacobus S, Supko JG, Stewart M, Choueiri TK, Gandhi L, Cleary JM, Elfiky AA, Taplin ME, Stack EC, Signoretti S, Loda M, et al. Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib. Cancer Discovery. 4: 546-53. PMID 24625776 DOI: 10.1158/2159-8290.Cd-13-0353 | 0.06 | |||
| 2008 | Stack EC, Matson WR, Ferrante RJ. Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants. Annals of the New York Academy of Sciences. 1147: 79-92. PMID 19076433 DOI: 10.1196/Annals.1427.008 | 0.06 | |||
| 2015 | Bambury RM, Bhatt AS, Riester M, Pedamallu CS, Duke F, Bellmunt J, Stack EC, Werner L, Park R, Iyer G, Loda M, Kantoff PW, Michor F, Meyerson M, Rosenberg JE. DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors. Bmc Cancer. 15: 242. PMID 25886454 DOI: 10.1186/S12885-015-1192-2 | 0.059 | |||
| 2016 | Althammer S, Steele K, Rebelatto M, Tan TH, Wiestler T, Schmidt G, Higgs B, Li X, Shi L, Jin X, Antal J, Gupta A, Ranade K, Binning G, Bellmunt J, ... ... Stack E, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0191-4 | 0.056 | |||
| 2015 | Carey CD, Connelly C, Gjini E, Roemer MG, Stack E, Hodi S, Shipp MA, Rodig SJ. Quantitative Assessment of PD-L1 Expression in Classical Hodgkin Lymphoma Suggests a Critical Role for Tumor Associated Macrophages in Suppressing Anti-Tumor Immunity Blood. 126: 1440-1440. DOI: 10.1182/blood.v126.23.1440.1440 | 0.054 | |||
| 2014 | Riester M, Werner L, Bellmunt J, Selvarajah S, Guancial EA, Weir BA, Stack EC, Park RS, O'Brien R, Schutz FA, Choueiri TK, Signoretti S, Lloreta J, Marchionni L, Gallardo E, et al. Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 1873-83. PMID 24486590 DOI: 10.1158/1078-0432.Ccr-13-0759 | 0.053 | |||
| 2016 | Ager C, Reilley M, Nicholas C, Bartkowiak T, Jaiswal A, Curran M, Albershardt TC, Bajaj A, Archer JF, Reeves RS, Ngo LY, Berglund P, ter Meulen J, Denis C, Ghadially H, ... ... Stack E, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0173-6 | 0.052 | |||
| 2014 | Choueiri TK, Jacobus S, Bellmunt J, Qu A, Appleman LJ, Tretter C, Bubley GJ, Stack EC, Signoretti S, Walsh M, Steele G, Hirsch M, Sweeney CJ, Taplin ME, Kibel AS, et al. Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1889-94. PMID 24821883 DOI: 10.1200/JCO.2013.52.4785 | 0.048 | |||
| 2015 | Wendik B, Mansfield J, Hoyt C, Stack E, Feldmann M, Bifulco C, Fox B. Imaging in cancer immunology: Phenotyping of multiple immune cell subsets in-situ in FFPE tissue sections Annals of Oncology. 26: viii5. DOI: 10.1093/annonc/mdv514.32 | 0.043 | |||
| 1994 | LoPachin RM, Lehning EJ, Stack EC, Hussein SJ, Saubermann AJ. 2,5-Hexanedione alters elemental composition and water content of rat peripheral nerve myelinated axons. Journal of Neurochemistry. 63: 2266-78. PMID 7964747 | 0.039 | |||
| 2013 | Riester M, Bellmunt J, Stack EC, Werner L, Park R, Iyer G, Loda M, Kantoff PW, Michor F, Rosenberg JE. Genomic characterization of metastatic urothelial carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 247. PMID 28136803 DOI: 10.1200/Jco.2013.31.6_Suppl.247 | 0.035 | |||
| 2012 | Molins JB, Werner L, Guix M, Guancial EA, Schutz FAB, O'Brien R, Stack EC, Loda MF, Berman DM, Hirsch MS, Signoretti S, Gallardo E, Rojo F, Ross RW, Kantoff P, et al. PI3KCA mutations in advanced urothelial carcinoma: A potential therapeutic target? Journal of Clinical Oncology. 30: 4582-4582. DOI: 10.1200/jco.2012.30.15_suppl.4582 | 0.033 | |||
| 1994 | LoPachin RM, Lehning EJ, Stack EC, Saubermann AJ. Disruption of Schwann cell elemental composition is not a primary neurotoxic effect of 2,5-hexanedione. Neurotoxicology. 15: 927-34. PMID 7715863 | 0.033 | |||
| 2017 | Carey CD, Gusenleitner D, Lipschitz M, Roemer MGM, Stack EC, Gjini E, Hu X, Redd R, Freeman GJ, Neuberg D, Hodi FS, Liu XS, Shipp MA, Rodig SJ. Topological analysis reveals a PD-L1 associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma. Blood. PMID 28893733 DOI: 10.1182/Blood-2017-03-770719 | 0.032 | |||
| 2013 | Norden AD, Lesser GJ, Drappatz J, Ligon KL, Hammond SN, Lee EQ, Reardon DR, Fadul CE, Plotkin SR, Batchelor TT, Zhu JJ, Beroukhim R, Muzikansky A, Doherty L, Lafrankie D, ... ... Stack EC, et al. Phase 2 study of dose-intense temozolomide in recurrent glioblastoma. Neuro-Oncology. 15: 930-5. PMID 23553268 DOI: 10.1200/Jco.2011.29.15_Suppl.2038 | 0.018 | |||
| 2016 | Stack EC, Foukas PG, Lee PP. Multiplexed tissue biomarker imaging. Journal For Immunotherapy of Cancer. 4: 9. PMID 26885371 DOI: 10.1186/s40425-016-0115-3 | 0.01 | |||
| Hide low-probability matches. | |||||